Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | 8.53% | 147.38 | 0.0% | $973.12m | |
AMGN | Amgen, Inc. | 0.61% | 254.60 | 1.5% | $857.20m | |
GILD | Gilead Sciences, Inc. | 0.35% | 64.70 | 1.0% | $546.77m | |
VRTX | Vertex Pharmaceuticals, Inc. | 1.42% | 273.47 | 1.9% | $494.63m | |
REGN | Regeneron Pharmaceuticals, Inc. | 1.25% | 691.95 | 2.6% | $439.95m | |
ILMN | Illumina, Inc. | 5.90% | 257.93 | 3.3% | $331.94m | |
NVAX | Novavax, Inc. | 17.10% | 55.12 | 75.7% | $302.64m | |
BIIB | Biogen, Inc. | 0.86% | 205.98 | 1.8% | $234.71m | |
BNTX | BioNTech SE | 5.29% | 166.52 | 0.0% | $222.15m | |
SNSS | Sunesis Pharmaceuticals, Inc. | 1.91% | 2.14 | 0.7% | $149.59m | |
EXAS | EXACT Sciences Corp. | 7.50% | 53.60 | 17.7% | $137.81m | |
TECH | Bio-Techne Corp. | 5.71% | 386.16 | 4.5% | $106.03m | |
TXG | 10X Genomics, Inc. | 11.30% | 52.70 | 0.0% | $105.86m | |
BMRN | BioMarin Pharmaceutical, Inc. | 2.50% | 80.83 | 4.2% | $96.91m | |
CRSP | CRISPR Therapeutics AG | 5.09% | 58.04 | 0.6% | $84.49m |
Company Profile
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.